Sep. 2, 2010 (Business Wire) -- Trading on the Tel Aviv Stock Exchange (TASE) during the last week was marked by high volatility and price gains in all leading indices, in keeping with the global trend.
The TA-25 index which gained 1.6% over the week is now higher by 1.1% from its level at the beginning of the year, following a 75% increase in 2009.
The TA-100 index increased by 1.9% and is now higher by 0.3% from its level at the beginning of this year. This follows a sharp increase of 89% attained in 2009.
The Tel Tech-15, index of large technology companies, affected by trading on Nasdaq, rose by 3.1%, the Real Estate-15 index gained 1.2% and the Finance index almost remained unchanged.
Shares of the U.S. biomed firm, Protalix BioTherapeutics, Inc. has been approved for listing on the Tel Aviv Stock Exchange, trading will start on September 6, 2010. The company is already traded on NYSE AMEX and joins the 45 companies dually-listed on major U.S. exchanges and TASE.
Figures released by Israel’s Central Bureau of Statistic indicate that unemployment rate in the second quarter of 2010 dropped to 6.2%, compared to 7.0% in the previous quarter and to 7.6% - the average in 2009.
About TASE
Established in September 1935, the Tel-Aviv Stock Exchange is Israel’s sole stock exchange, offering an increasingly sophisticated range of products to investors, including equity, corporate bonds, treasury bills and notes, index products and derivatives. The Tel-Aviv Stock Exchange features 611 companies listing equities, 406 index-tracking products, 34 series of government bonds, 636 series of corporate bonds and 1,239 mutual funds. As of July 2010, the exchange’s market capitalization in equities was about US$183 billion. In recent years, the exchange has enhanced its international presence, signing Memorandums of Understanding with the London Stock Exchange, NASDAQ, the Shanghai Stock Exchange, Toronto Stock Exchange and NYSE-Euronext.
Visit the Tel Aviv Stock Exchange's Website: www.tase.co.il
Grayling
Alistair Scott or Jonathan Shillington, 020-7255-1100
or
TASE
Idit
Yaaron or Orna Goren, 972-3-5677564/405
